Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD+-dependent sirtuin-3 activation
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, but its pathogenesis is unclear. Here we focus on histidine triad nucleotide-binding protein 2 (HINT2), which is expressed in the mitochondria and is involved in hepatic lipid metaboli...
Saved in:
| Main Authors: | Qinqiu Wang, Yanjun Guo, Shenghui Chen, Zhening Liu, Xinyu Wang, Hangkai Huang, Qi-en Shen, Ling Yang, Meng Li, Youming Li, Chaohui Yu, Chengfu Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Experimental and Molecular Medicine |
| Online Access: | https://doi.org/10.1038/s12276-025-01445-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histidine triad nucleotide‐binding protein 2 attenuates doxorubicin‐induced cardiotoxicity through restoring lysosomal function and promoting autophagy in mice
by: Hao Jiang, et al.
Published: (2025-03-01) -
Laparoscopically confirmed endometriosis and the risk of incident NAFLD: a prospective cohort study
by: Hangkai Huang, et al.
Published: (2025-04-01) -
The clinical value of serum sirtuin-1 concentration in the diagnosis of metabolic dysfunction-associated steatotic liver disease
by: Farshad Amirkhizi, et al.
Published: (2025-01-01) -
Human neutrophil defensin-1 binding increases histidine kinase activity of SaeS in Staphylococcus aureus
by: Zhengfei Qi, et al.
Published: (2025-06-01) -
Triad Science based on Triad Logic
by: YE Ying
Published: (2000-05-01)